您的购物车当前为空
别名 依珠曲米, VOX-C1100, SMT C1100, BMN 195
Ezutromid (BMN 195) 是一种具有口服活性的、首创的苯并恶唑 utrophin 调节剂,EC50=0.91 μM。它抑制人肝微粒体 CYP1A2 酶活性,IC50=5.4 μM。它可用于 Duchenne 型肌营养不良症 (DMD) 的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Ezutromid (BMN 195) 是一种具有口服活性的、首创的苯并恶唑 utrophin 调节剂,EC50=0.91 μM。它抑制人肝微粒体 CYP1A2 酶活性,IC50=5.4 μM。它可用于 Duchenne 型肌营养不良症 (DMD) 的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 170 | In stock | |
| 5 mg | ¥ 398 | In stock | |
| 10 mg | ¥ 636 | In stock | |
| 25 mg | ¥ 1,270 | In stock | |
| 50 mg | ¥ 2,030 | In stock | |
| 100 mg | ¥ 3,270 | In stock | |
| 200 mg | ¥ 4,490 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 437 | In stock |
Ezutromid 相关产品
| 产品描述 | Ezutromid (BMN 195) is a translation modulator of Small utrophin (EC50: 0.4 uM). Ezutromid is an orally bioavailable small molecule that transcriptionally upregulates the utrophin gene, increasing both utrophin mRNA and protein. Through this action, Ezutromid increases muscle function in dystrophin-deficient MDX mice, a mouse model of muscular dystrophy. |
| 靶点活性 | Small utrophin:0.4 μM |
| 别名 | 依珠曲米, VOX-C1100, SMT C1100, BMN 195 |
| 分子量 | 337.39 |
| 分子式 | C19H15NO3S |
| CAS No. | 945531-77-1 |
| Smiles | S(CC)(=O)(=O)C=1C=C2N=C(OC2=CC1)C3=CC4=C(C=C3)C=CC=C4 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 12 mg/mL (35.57 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容